General
Release from Glaxo Smith Kline (BIOC.CA) Concerning the Board of Directors & the Executive Managers
Published at 19 July 2026 at 08:46Glaxo Smith KlineRelated stock:Glaxo Smith Kline stockAll Glaxo Smith Kline disclosures
Disclosure summary
Company: Glaxo Smith Kline
Symbols: EGS38171C012
Reuters: BIOC.CA
Content:
Release from the company concerning the Board of Directors & the Executive Managers.
The Release (533 KB)
Symbols: EGS38171C012
Reuters: BIOC.CA
Content:
Release from the company concerning the Board of Directors & the Executive Managers.
The Release (533 KB)